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There is an art to science, and science in art;
the two are not enemies, but different aspects ofthewhole.
IsaacAsimov, 1988
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Breast Cancer and MCS in EHP
In recent years, much progress has been
made in understanding why certain women
develop breast cancer, and several studies
have proposed that environmental factors
can significantly affect a person's likelihood
of the disease. Despite these advances, the
mechanisms underlying cancer largely
remain a mystery. Similarly, many
researchers have suggested that the recently
diagnosed phenomenon known as multiple
chemical sensitivity (MCS) could be caused
by exposure to environmental toxins, but
how these chemicals enter the body and
cause such a reaction remains a mystery.
EHPwill publish two monographs contain-
ing important research on these subjects,
Experimental Approaches to Chemical
Sensitivity in March 1997 and Hormones,
Hormone Metabolism, and Breast Cancer in
April 1997.
MCS is apoorly understood condition in
which patients have severe reactions to chem-
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icals in concentrations that most people can
easily tolerate. Perfumes, household deaners,
and petroleum-based products have been
reported to cause illness in some patients suf-
fering from MCS. Chemicals, however, do
not always trigger the same responses among
different MCS patients and, although some
patients have reported past exposure to a
known toxicant that coincided with the
onset of MCS, others can report no such
exposure, making the condition difficult to
characterize anddiagnose.
Clinical ecologists have long suggested
that exposure to low levels ofchemicals can
cause physiological responses in genetically
susceptible persons including illnesses such as
cancer and arthritis. On the other hand, in
an attempt to distinguish the condition from
known occupational diseases and psychiatric
conditions, the occupational health literature
has provided a definition ofMCS as a novel
condition that could possibly be acquired
through classic conditioning. Each approach
Neuropsychological
*Multiple chemicalsensitivity
*Attention deficithyperactivity
disorder(ADHD)
*Depression/manic depression
* Migraines and otherheadaches
*Seizures
Arrhythmias
*Hypertension
*Hypotension
' -Raynaud's phenomenon
Miscellaneous
' Chronic fatigue syndrome
' Implantsyndromes
' GulfWarsyndrome
Respiratory
Asthma
Reactive airwaysdysfunction
syndrome(RADS)
Toluenedilsocyanate (TDI)
hypersensitivity
Skin
*Eczema
' Hives
' Otherrashes, eruptions
,Gastrointestinal
Irritable bowel
Reflux
Connectivetissue/musculoskeletal
Fibromyalgia
Carpaltunnelsyndrome
Temporomandibular joint(TMJ) dysfunction syndrome
Arthritis
*Lupus
The mystery of MCS. Characterizing multiple chemical sensitivity is made difficult by the broad range of
symptoms associated with it.
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carries different implications for how MCS
should be studied and what kind of treat-
ments are likelyto be effective.
"Ifthis is apurelypsychological phenom-
enon-that is, one that is conditioned-then
it can be learned or unlearned," says Nancy
Fiedler, associate professor in the
Environmental and Occupational Health
Sciences Institute of the Robert Woods
Johnson Medical School, who led the MCS
workshop that prompted the MCS mono-
graph. "On the other hand, others would
suggest that we need to extend the
dose-response curves to includephysiological
responses that can be brought on byvery low
doses. These are responses that cannot be
unlearned ... through psychiatric therapy."
Other researchers disagree with the
notion that MCS can be effectivelystudied as
eitherapurelypsychological orpurelyphysio-
logical phenomenon. Some have suggested
that stress must accompany a toxic exposure
to initiate sensitivity. Others propose that an
initiating exposure can affect the physiology
ofthe brain through a process similar to the
limbic kindling seen in animals, through
which intermittentlow-level stimuli can cause
the brain to change so that further stimulus
will initiate full-blown seizures. According to
Iris Bell, director of the Geriatric Psychiatry
program at the Tucson Veterans Affairs
Medical Center, "The mind versus body con-
ceptualization of MCS is extremely erro-
neous." Bell says that a better understanding
of the field of psychology would allow
researchers to better understand MCS as a
complexmind-bodyinteraction.
ExperimentalApproaches to Chemical
Sensitivity attempts to provide a basis for
comparing the different approaches toward
MCS in hopes of developing a unified
research strategy. Some papers in the mono-
graph deal with clinical case studies that
describe various symptoms and characteris-
tics of MCS patients. Other papers propose
models for MCS, describing the condition as
related to the learning process, to time-
dependent sensitization, or to the mecha-
nisms underlying drug abuse. Still others
suggest experimental methods and variables
that could be employed in experimental
studies ofMCS.
Hormones, Hormone. Metabolism, and
Breast Cancer is dedicated to the issues of
breast cancer and the effects ofhormones on
Volume 105, Number3, March 1997 a EnvironmentalHealth Perspectives
I'rdiwart-ilar
274Forum
Xenohormones,
endogenous hormones
CYP450-dependent 17p-oxidoreductase aromatase
Total bioavailable estradiol
E2 ' El
CYP450-dependent hydroxylases
2-OHEI, 2-OHE2 16a-OHE1,4-OHEl
2-MeOHE1 4-OHE2
(E2 antagonists) (E2 agonists)
ER, PgR,AR, EGFR,TGFa,TGF-,BR
IGFR-mediated responses
Aberrant proliferation
Gapjunction inhibition
Breast cancer
Hormones and breast cancer. Steroid hormone
metabolites having estrogenic or antiestrogenic
properties exert their growth modulatory effects
indirectly via receptor-mediated mechanisms,
leadingtoaberrantproliferation andbreastcancer.
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the development of this disease, the most
common cancer among women. An October
1993 petition signed by 2.6 million people
asked President Clinton for a newstrategyto
fight breast cancer. This petition led to the
development ofthe National Action Plan on
Breast Cancer (NAPBC). The Etiology
Working Group of the NAPBC, together
with the National Cancer Institute, Tulane
University's Center for Bioenvironmental
Research, and the U.S. Public Health
Service's Office of Women's Health con-
vened a workshop on hormones and breast
cancer 28-29 September 1995. Selected
papers from this workshop, as well as some
response papers, form the basis ofHormones,
HormoneMetabolism, andBreast Cancer.
Modern epidemiological studies have
found that most of the known risk factors
for breast cancer, excluding radiation, are
directly related to lifetime exposure to estra-
diol and other hormones. Researchers have
reasoned that any environmental chemical
that has the ability to mimic human hor-
mones or affect their metabolism may be
carcinogenic. However, some xenohormones
(such as DDT) appear to be harmful, while
others (such as phytoestrogens) appear to be
protective. The mechanisms by which xeno-
hormones influence bodily processes, poten-
tially leading to cancer, have not been deci-
sively identified. The papers presented in
Hormones, Hormone Metabolism, and Breast
Cancercontribute to elucidating these mech-
anisms and differentiating among helpful
and harmful hormones.
The monograph also includes views and
concerns of some breast cancer research
advocates. For example, Sandra Steingraber
ofthe Women's Community Cancer Project
writes about her concern that more work is
being done to identify the mechanisms of
cancer than is beingdone to protect thepub-
lic from the disease. "We are interested in
research that identifies breast carcinogens,
and we [are also] interested in social changes
thatwould keep these agents out ofwomen's
breasts in the first place," says Steingraber. In
another paper, Craig Dees ofthe Oak Ridge
National Laboratory and colleagues propose
that the colorant Red Number 3 causes
genetic damage and could be a significant
riskfactor for breast cancer.
Other researchers present additional sup-
port for a link between sex hormone levels
and breast cancer incidence. One nested
case-control study by Joanne F. Dorgan of
the National Cancer Institute and colleagues
examines serum estrogen levels and cancer
incidence in postmenopausal women.
Another paper finds that dietary estrogens at
low concentrations can stimulate human
breast cells to begin replication. In a paper
by Ruth H. Allen of the National Cancer
Institute and colleagues, the relationship
between increasing breast cancer incidence
amongwomen in Hawaii and the use ofpes-
ticides there provides evidence of a link
betweenxenohormones and cancer risk.
Research on the link between
known risk factors for breast
cancer and lifetime expo-
sure to bioavailable
estradiol has led to the
idea that xenohor-
mones can affect the
body by two dis-
tinct paths, either
by attacking DNA
directly orby inter-
actingwith endoge-
nous hormones and
altering the forma-
tion of hormone
metabolites. A paper by
Takeki Tsutsui of the _
Nippon Dental University and
colleagues found evidence of DNA
adduct formation and aneuploidy induction
(precursors to cancer) in response to estro-
gen. The mechanism by which phytoestro-
gens maywork to prevent cancers is discussd
in Hormones, Hormone Metabolism, and
Breast Cancer, and monograph authors sug-
gest that these chemicals act to reduce the
binding of other xenoestrogens to human
estrogen receptors. It is also suggested in the
monograph that the presence or absence of
lipophilic regions on estrogens and xenoe-
strogens mayaffect their binding characteris-
tics and cold be used to distinguish harmful
estrogens from beneficial ones.
The papers presented in Hormones,
HormoneMetabolism, andBreast Canceralso
discuss ways of measuring human hormone
levels as a means ofassessing an individual's
risk ofdeveloping breast cancer. Researchers
compared the sensitivity of two competing
methods ofmeasuring hormone metabolites
(2-hydroxyestrone and 16a-hydroxyestrone
immunoassays) and found a high degree of
agreement for premenopausal women, a
finding that could lead to more refined
methods of measurement. Other authors
identified ways to measure xenoestrogen lev-
els in human serum. According to Devra
Davis, program director of the Health,
Environment, and Development Program of
the World Resources Institute and an editor
of the monograph, better methods of mea-
suring hormone levels will make it easier for
scientists to identify environmental carcino-
gens. "Experimental methods for identifying
hazards need to be developed, and measur-
ing [xenohormone] levels present [in the
body] is a very direct way ofassessing expo-
sure." Davis said that future research should
concentrate on these issues.
New Dimensions to Dementia
Two studies published last September pro-
vide new clues to possible links between
environmental factors and neurode-
generative diseases. Both genetic
and environmental factors
are thought to play a role
in the development of
such diseases. How-
ever, until now,
C"more progress has
been made on the
genetic side of the
equation," says
George Martin, dir-
i,
I_d. ector of the Alzhei-
mer's Disease Research
Center at the University
ofWashington in Seattle.
These studies and others like
them are the latest attempts to
rectifythat imbalance.
The first study, published in the 25
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